Acute Lymphoblastic Leukaemia – imatinib mesylate Initial PBS authority application form (PB078)

Complete this form for a patient who is starting initial Pharmaceutical Benefits Scheme (PBS) subsidised treatment with imatinib mesylate for acute lymphoblastic leukaemia.


Page last updated: 15 June 2016

This information was printed Friday 30 September 2016 from It may not include all of the relevant information on this topic. Please consider any relevant site notices at when using this material.